Liberate Bio bags key CAR-M patents, eyes first clinical trials in 2026
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
The new patents cover critical advancements in cochlear implant technology
The portfolio includes foundational patents on the production, composition, and commercial use of NR
Marks remarkable acceleration in innovation using AI technology
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The competition received over 42 entries from nursing colleges across Maharashtra
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
Subscribe To Our Newsletter & Stay Updated